This minireview is an update of a 1997 review on erythropoletin (EPO) in this journal (1).
EPO is a 30,400-dalton glycoprotein that regulates red cell production. In the human, EPO is …

Synopsis Epoetin alfa is a recombinant form of the principal hormone responsible for
erythrogenesis, erythropoietin. Already an established treatment for anaemia associated …

This is a Minireview covering landmarks or milestones in the development of erythropoietin
(EPO). Thirty-nine landmark advances have been identified, which cover the period 1863 …

Recombinant human erythropoietin (rHuEPO) stimulates erythropoietic bone marrow cells
and increases erythrocyte production. This prospective study was designed to evaluate the …

Erythropoietin (EPO) is an endogenous hormone produced in the kidney that regulates red
blood cell production within the body. Since the cloning and first clinical introduction of …

BACKGROUND: Most patients undergoing allogeneic marrow transplantation (alloBMT)
require transfusions of RBCs. A retrospective analysis was performed to evaluate the …

We conducted a prospective randomized trial to assess hemoglobin (Hb) response to
recombinant human erythropoietin (rhEPO) therapy after hematopoietic cell transplantation …

After allogeneic stem cell transplantation (allo-SCT) some patients develop persistent
anemia in association with an inadequate erythropoietin (Epo) secretion. We determined the …

OBJECTIVE: Allogeneic hematopoietic stem cell transplantation (HSCT) is associated with
prolonged anemia caused by defective erythropoietin (Epo) production. We enrolled 34 …

BACKGROUND Integrating evidence from randomized controlled trials (RCTs) into patient
care is needed to optimize patient outcomes. Transfusion support during allogeneic …